The yellow fever 17D vaccine and risk of malignant melanoma in the United States military

Vaccine

Volumn 30, Issue 30, 2012, Pages 4476-4479

  Hodges Vazquez, Meredith ^a   Wilson, James P ^a   Hughes, Hayley ^b   Garman, Patrick ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Military Vaccine Agency   (United States)

Author keywords

Melanoma; Nested case control study; Yellow fever vaccine

Indexed keywords

YELLOW FEVER VACCINE;

ADULT; ARMY; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; UNITED STATES; VACCINATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MILITARY PERSONNEL; RISK FACTORS; UNITED STATES; YELLOW FEVER VACCINE;

EID: 84862016348     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.074     Document Type: Article

References (23)

1. Vries E.D., Coeburgh J. Cutaneous malignant melanoma in Europe. European Journal of Cancer 2004, 40:2355-2366.
2. Mansson-Brahme E., Johansson H., Larsson O., Rutqvist L., Ringborg U. Trends in incidence of cutaneous malignant melanoma in a Swedish population, 1976 to 1994. Acta Oncology 2002, 41:138-146.
3. Lasithiotakis K., Leiter U., Gorkievicz R., Eigentler T., Breuninger H., Metzler G., et al. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 2006, 107:1331-1339.
4. Ulmer M., Tonita J., Hull P. Trends in invasive cutaneous melanoma in Saskatchewan 1970-1999. Journal of Cutaneous Medicine and Surgery 2003, 7:433-442.
5. Geller A., Miller D., Annas G., Demierre M., Gilchrest B., Koh H. Melanoma incidence and mortality among US whites, 1969-1999. Journal of the American Medical Association 2002, 288(14):1719-1720.
6. Linos E., Swetter S., Cockburn M., Colditz G., Clarke C. Increasing burden of melanoma in the United States. Journal of Investigative Dermatology 2009, 1666-1674.
7. Garbe C., Leiter U. Melanoma and epidemiology trends. Clinics in Dermatology 2009, 27:3-9.
8. Krone B., Kolmel K., Grange J., Mastrangelo G., Henz B., Botev I., et al. Impact of vaccinations and infectious diseases on the risk of melanoma-evaluation of an EORTC case-control study. European Journal of Cancer 2003, 39:2372-2378.
9. Pfahlberg A., Kolmel K., Grange J., Mastrangelo G., Krone B., Botev I., et al. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. Journal of Investigative Dermatology 2002, 119:570-575.
10. Kolmel K., Grange J., Krone B., Mastrangelo G., Rossi C., Henz B., et al. Prior immunization of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. European Journal of Cancer 2005, 41:118-125.
11. Krone B., Kolmel K.F., Henz B.M., Grange J.M. Protection against melanoma by vaccination with Bacille Calmette Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control. European Journal of Cancer 2005, 41:104-117.
12. Mastrangelo G., Krone B., Fadda E., Buja A., Grange J., Rausa G., et al. Does yellow fever 17D vaccine protect against melanoma?. Vaccine 2009, 27:588-591.
13. Rubertone M.V., Brundage J.F. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. American Journal of Public Health 2002, 92(12):1900-1904.
14. Armed Forces Health Surveillance Center Incident diagnoses of malignant melanoma, active components, U.S. Armed Forces, January 1998-June 2008. Medical Surveillance Monthly Report 2008, 15(9):6-9.
15. Etminan M. Pharmacoepidemiology II: the nested case-control study - a novel approach in pharmacoepidemiologic research. Pharmacotherapy 2004, 24(9):1105-1109.
16. Centers for Disease Control and Prevention Health Information for International Travel, 2008 2008, U.S. Department of Health and Human Services, Atlanta, GA.
17. Centers for Disease Control and Prevention General recommendation on immunization: recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR. Recommendations and Reports 2006, 51(RR-15):1-48.
18. Zhu K., Devesa S., Hongyu W., Hoar Zham S., Jatoi I., Anderson W., et al. Cancer incidence in the U.S. military population: comparison with rates from the SEER Program. Cancer Epidemiology, Biomarkers & Prevention 2009, 18(6):1740-1745.
19. Kennedy K. Troops have higher rates of some cancers 2010, Army Times Publishing Company, Army Times.
20. Centers for Disease Control and Prevention TB Elimination: BCG Vaccine 2011, US Department of Health and Human Services, Atlanta, GA, cited 2012 April 16; Available from: http://www.cdc.gov/tb/publications/factsheets/vaccine/BCG.pdf?s_cid=cs_476.
21. Parrino J., Graham B.S. Smallpox vaccines: past, present, and future. The Journal of Allergy and Clinical Immunology 2006, 118:1320-1326.
22. Grabenstein J., Winkenwerder W. US Military smallpox vaccination program experience. Journal of the American Medical Association 2003, 289(24):3278-3282.
23. Mastrangelo G., Rossi C.R., Pfahlberg A., Marzia V., Barba A., Baldo M., et al. Is there a relationship between influenza vaccinations and risk of melanoma? A population-based case-control study. European Journal of Epidemiology 2000, 16:777-782.